Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in H1 2026

European Healthtech startup funding raised during H1 2026.

In H1 2026, 234 European Healthtech companies closed 237 funding rounds and raised €4.1B in equity funding (excluding debt and grants), up 3.5% versus H1 2025. Debt rounds added €181M. UK led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 20 Nov 2026.

Equity funding
€4.1B
+3.5% vs H1 2025 · excl. debt & grants · +€181M debt
Funding rounds
237
-0.8% vs H1 2025
Companies
234
Top country
UK
Rank among sectors
#5
8.9% of sector funding
Debt financing
€181M
4.2% of total
Top-10 round share
58.7%
of disclosed capital
Rounds ≥ €100M
3

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, H1 2026 — interactive chart.
Data table
FundingRounds
Jan€850M51
Feb€446M40
Mar€279M42
Apr€253M35
May€2.0B33
Jun€486M36

Top countries

by € raised
Healthtech — top countries by capital, H1 2026 — interactive chart.
Data table
Healthtech — top countries by capital, H1 2026
UK€2.6B
France€402M
Germany€319M
Switzerland€219M
Netherlands€195M
Spain€195M
Ireland€114M
Iceland€100M

Stage mix

by € raised
Healthtech — stage mix, H1 2026 — interactive chart.
Data table
Healthtech — stage mix, H1 2026
Series B€2.1B
Other€732M
Series A€440M
Series D+€298M
Series C€277M
Debt€181M
Seed€169M
Grant€61M
Growth/Late€57M
Pre-Seed€22M
Crowdfunding€233k

Exits & M&A

17 Acquisition

17 exits · €1.0B disclosed.

Saga DiagnosticsAcquisitionApr 2026€504M
Kaia HealthAcquisitionJan 2026€239M
GleamerAcquisitionMar 2026€230M

Top deals

largest disclosed rounds in H1 2026
CompanyStageDateAmount
Isomorphic LabsSeries BMay 2026€1.8B
OvivaSeries D+Jan 2026€200M
AlvotechDebtJan 2026€100M
CeQurSeries D+Jun 2026€86M
Ona TherapeuticsSeries BJun 2026€74M
DentalMonitoringOtherFeb 2026€71M
Neurent MedicalSeries CFeb 2026€63M
VitestroSeries BMar 2026€60M
UromemsGrowth/LateMay 2026€52M
ExcivaSeries BJan 2026€51M
FineHeartGrantJan 2026€48M
Storm TherapeuticsSeries CApr 2026€48M
NVision ImagingSeries BMay 2026€47M
IMU BiosciencesOtherJun 2026€45M
BiorceSeries AFeb 2026€44M

Top investors

most active in H1 2026, by deal count